Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations

• Published in: Statistics in medicine Vol. 17; no. 10; pp. 1121 - 1136
• Main Authors: Longini Jr, Ira M., Sagatelian, Karen, Rida, Wasima N., Halloran, M. Elizabeth
• Format: Journal Article
• Language: English
• Published: Chichester Wiley Subscription Services, Inc., A Wiley Company 30.05.1998; Wiley
• Subjects: Biological and medical sciences; Clinical Trials as Topic - statistics & numerical data; Communicable Disease Control - statistics & numerical data; Disease Susceptibility - epidemiology; Disease Susceptibility - prevention & control; General aspects; Humans; Medical sciences; Models, Statistical; Planification. Prevention (methods). Intervention. Evaluation; Public health. Hygiene; Public health. Hygiene-occupational medicine; Research Design; Risk; Treatment Outcome; Vaccination - statistics & numerical data; Parameter estimation; Efficiency; Infectious risk; Vaccination; Body contact; Statistical estimation; Public health; Contamination; Optimal design
• DOI: 10.1002/(SICI)1097-0258(19980530)17:10<1121::AID-SIM824>3.0.CO;2-E
• ISSN: 0277-6715

Vaccination can have important indirect effects on the spread of an infectious agent by reducing the level of infectiousness of vaccinees who become infected. To estimate the effect of vaccination on infectiousness, one typically requires data on the contacts between susceptible and infected vaccinated and unvaccinated people. As an alternative, we propose a trial design that involves multiple independent and interchangeable populations. By varying the fraction of susceptible people vaccinated across populations, we obtain an estimate of the reduction in infectiousness that depends only on incidence data from the vaccine and control groups of the multiple populations. One can also obtain from these data an estimate of the reduction of susceptibility to infection. We propose a vaccination strategy that is a trade‐off between optimal estimation of vaccine efficacy for susceptibility and of vaccine efficacy for infectiousness. We show that the optimal choice depends on the anticipated efficacy of the vaccine as well as the basic reproduction number of the underlying infectious disease process. Smaller vaccination fractions appear desirable when vaccine efficacy is likely high and the basic reproduction number is not large. This strategy avoids the potential for too few infections to occur to estimate vaccine efficacy parameters reliably. © 1998 John Wiley & Sons, Ltd.